| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-10 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |